Rossari Biotech reports Q4FY23 consolidated PAT at Rs. 28.97 Cr
General

Rossari Biotech reports Q4FY23 consolidated PAT at Rs. 28.97 Cr

The company has posted net profit of Rs.107.25 crores for the Financial Year ended March 31, 2023

  • By ICN Bureau | April 30, 2023

Rossari Biotech Limited has posted net profit of Rs. 28.97 crores for the quarter ended March 31, 2023 as against net profit of Rs.24.08 crores for the quarter ended March 31, 2022.

The company has reported total income of Rs. 409.27 crores during the quarter ended March 31, 2023 as compared to Rs.440.90 crores during the period ended March 31, 2022.

For the Financial Year ended FY2023, Rossari Biotech has reported total income of Rs.1661.36 crores as compared to Rs.1494.97 crores during the Financial Year ended March 31, 2022.

The company has posted net profit of Rs.107.25 crores for the Financial Year ended March 31, 2023 as against net profit of Rs.97.67 crores for the Financial Year ended March 31, 2022.

Upcoming E-conferences

ChemConnect 2024

October 25, 2024

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization